Experts are intently watching retatrutide, a novel medication showing encouraging results in real-world studies for weight loss . This double-action compound , targeting both glucose and gut-hormone pathways, suggests to deliver a significant step forward over available obesity-reducing approaches. Preliminary findings show greater impact in assis